tiprankstipranks
Trending News
More News >
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
US Market

Barinthus Biotherapeutics (BRNS) Stock Investors

Compare
91 Followers
Based on 794,582 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold BRNS
On average, investors allocate 0.00% of their portfolios to BRNS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 794,582 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding BRNS

1.2%
Last 7
Days
9.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding BRNS, out of 794,582 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

BRNS Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of investors who made their portfolios public
The table shows changes in BRNS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

BRNS Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Recursion Pharmaceuticals
3.21%
-0.80%
-1.63%
1.70B
Healthcare
UiPath
3.35%
-1.22%
-1.51%
5.54B
Technology
Riot Platforms
4.61%
-1.07%
-1.43%
2.50B
Financial
Marathon Digital Holdings
4.95%
-0.99%
-0.66%
3.91B
Financial
Viking Therapeutics
3.81%
-1.48%
-2.54%
2.54B
Healthcare
JD
4.98%
-0.96%
+1.27%
62.81B
Consumer Cyclical
Nio
8.82%
-0.53%
-0.63%
7.67B
Consumer Cyclical
Lucid Group
5.42%
+0.43%
+1.23%
6.91B
Consumer Cyclical
Devon Energy
3.93%
-0.53%
-0.20%
19.02B
Energy
Rivian Automotive
5.77%
-0.75%
-0.40%
12.68B
Consumer Cyclical
Based on the activity of 794,582 active portfolios
Open your Smart Portfolio

BRNS Investor Analysis

BRNS investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
4.8%
of BRNS holders
are under 35
Average Segment Performance
Average P/E Ratio16.83
Beta5.56
Dividend Yield4.09%
BRNS investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
61.9%
of BRNS holders
are between 35–55
Average Segment Performance
Average P/E Ratio16.92
Beta13.64
Dividend Yield3.58%
BRNS investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
33.3%
of BRNS holders
are over 55
Average Segment Performance
Average P/E Ratio13.94
Beta8.07
Dividend Yield3.86%
Overview of age group and performance of BRNS stock investors
See who invests in BRNS according to age group and performance.

FAQ

How many retail Investors hold BRNS?
<0.1% of TipRanks' retail investors hold BRNS in their portfolios.
    What is BRNS Investor Sentiment?
    BRNS’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of BRNS in the last 7 days?
      ▼ 1.2% of TipRanks' retail investors changed their holding of BRNS in the last 7 days.
        What percentage of retail investors changed their holding of BRNS in the last 30 days?
        ▼ 9.0% of TipRanks' retail investors changed their holding of BRNS in the last 30 days.
          What is the average age of retail investors who hold BRNS?
          The average age of BRNS Holders is between 35–55.
            What other stocks have BRNS investors also bought?
            BRNS Investors also bought RXRX, PATH, RIOT, MARA, VKTX, JD, NIO, LCID, DVN, RIVN.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              CORCencora
              BSXBoston Scientific
              GSKGlaxoSmithKline
              INSMInsmed
              JAZZJazz Pharmaceuticals
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis